GDF15 and myocardial infarction: We also investigated its direct cardiac effects in both in vivo and ex vivo models of I/R using recombinant GDF15 concentrations relevant to patients with a high CV risk, to assess the potential suitability of rGDF15 as a therapeutic strategy in the context of myocardial infarction.